M Kathleen Behrens's Net Worth
$20.1 Million
Who is M Kathleen Behrens?
M Kathleen Behrens has an estimated net worth of $20.1 Million. This is based on reported shares across multiple companies, which include MIMEDX GROUP, INC., Sarepta Therapeutics, Inc., IGM Biosciences, Inc., AMYLIN PHARMACEUTICALS INC, and ABGENIX INC.
SEC CIK
M Kathleen Behrens's CIK is 0001211701
Past Insider Trading and Trends
2020 was M Kathleen Behrens's most active year for acquiring shares with 21 total transactions. M Kathleen Behrens's most active month to acquire stocks was the month of February. 2006 was M Kathleen Behrens's most active year for disposing of shares, totalling 10 transactions. M Kathleen Behrens's most active month to dispose stocks was the month of March. 2020 saw M Kathleen Behrens paying a total of $5,998,362.03 for 156,003 shares, this is the most they've acquired in one year. In 2006 M Kathleen Behrens cashed out on 356,217 shares for a total of $3,289,882.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MIMEDX GROUP, INC. (MDXG) Snapshot price: $7.75
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +28.14% | 35.35K |
$4.95 | $175,002.30 | 160.97K |
Jun 13
| |||
Form 4
| +54.27% | 44.19K |
$3.96 | $174,996.36 | 125.62K |
Jun 7
| |||
Form 4
| +26.50% | 17.06K |
$10.26 | $174,994.56 | 81.43K |
May 27
| |||
Form 4
| +68.80% | 26.24K |
$6.67 | $174,994.12 | 64.37K |
Oct 2
| |||
Form 4
|
∞
| 38.13K |
—
|
—
| 38.13K |
Aug 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sarepta Therapeutics, Inc. (SRPT) Snapshot price: $126.41
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.05% | 1.85K |
—
|
—
| 176.84K |
Mar 1
| |||
Form 4
| +9.38% | 15K |
$29.03 | $435,450.00 | 174.99K |
Nov 3
| |||
Form 4
| +0.96% | 1.52K |
—
|
—
| 159.99K |
Mar 6
| |||
Form 4
| +14.44% | 20K |
$34.92 | $698,400.00 | 158.47K |
Dec 19
| |||
Form 4
| +2.18% | 2.95K |
—
|
—
| 138.47K |
Mar 7
| |||
Form 4
| +3.83% | 5K |
$10.08 | $50,400.00 | 135.52K |
Dec 15
| |||
Form 4
|
—
|
0
|
$64.03 | -$217,300.00 | 130.52K |
Mar 10
| |||
Form 4
| +2.13% | 2.73K |
—
|
—
| 130.52K |
Mar 3
| |||
Form 4
| +1.65% | 2.08K |
—
|
—
| 127.74K |
Feb 28
| |||
Form 4
| +6.35% | 7.5K |
$34.53 | $258,950.00 | 125.67K |
Sep 5 - Sep 6
| |||
Form 4
| +1.40% | 1.63K |
—
|
—
| 118.17K |
Mar 4
| |||
Form 4
|
—
|
0
|
$67.84 | -$1,277,500.00 | 116.53K |
Oct 31
| |||
Form 4
| +3.02% | 3.42K |
—
|
—
| 116.53K |
Mar 5
| |||
Form 4
| +0.89% | 1K |
—
|
—
| 113.12K |
Mar 10
| |||
Form 4
| +0.89% | 1K |
—
|
—
| 113.12K |
Mar 10
| |||
Form 4
| +127.07% | 75K |
$15.54 | $1,220,708.50 | 134.02K |
Mar 14 - Mar 16
| |||
Form 4
| +2.17% | 1K |
—
|
—
| 47.17K |
Feb 29
| |||
Form 4
| +2.21% | 1K |
—
|
—
| 46.17K |
Feb 27
| |||
Form 4
| +2.26% | 1K |
—
|
—
| 45.17K |
Feb 28
| |||
Form 4
| +17.26% | 6.5K |
$37.04 | $240,778.20 | 44.17K |
Sep 16
| |||
Form 4
| +2.73% | 1K |
—
|
—
| 37.67K |
Jun 4
| |||
Form 4
| +91.31% | 17.5K |
$14.73 | $257,724.00 | 36.67K |
Sep 7
| |||
Form 4
| +4.54% | 833 |
—
|
—
| 19.17K |
Aug 23
| |||
Form 4
| +4.76% | 5K |
—
|
—
| 110K |
Jun 21
| |||
Form 4
| +2,000.00% | 100K |
$1.50 | $150,000.00 | 105K |
Apr 6
| |||
Form 4
|
∞
| 5K |
—
|
—
| 5K |
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IGM Biosciences, Inc. (IGMS) Snapshot price: $10.86
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +44.17% | 3.08K |
—
|
—
| 10.05K |
Mar 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 4
| +12.97% | 800 |
—
|
—
| 6.97K |
Dec 29
| |||
Form 4
| +14.90% | 800 |
—
|
—
| 6.17K |
Sep 29
| |||
Form 4
| +17.51% | 800 |
—
|
—
| 5.37K |
Jun 30
| |||
Form 4
| +51.56% | 112.5K |
$8.00 | $900,000.00 | 330.7K |
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 4
| |||
Form 4
| +21.23% | 800 |
—
|
—
| 4.57K |
Mar 31
| |||
Form 4
| +11.02% | 374 |
—
|
—
| 3.77K |
Dec 30
| |||
Form 4
| +37.93% | 60K |
$17.14 | $1,028,550.00 | 218.2K |
Nov 8
| |||
Form 4
| +12.38% | 374 |
—
|
—
| 3.39K |
Sep 30
| |||
Form 4
| +14.13% | 374 |
—
|
—
| 3.02K |
Jun 30
| |||
Form 4
| +38.47% | 61.24K |
$23.00 | $1,399,987.00 | 220.46K |
Mar 31 - Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 4
| +10.24% | 211 |
—
|
—
| 2.27K |
Dec 31
| |||
Form 4
| +11.41% | 211 |
—
|
—
| 2.06K |
Sep 30
| |||
Form 4
| +12.87% | 211 |
—
|
—
| 1.85K |
Jun 30
| |||
Form 4
| +0.22% | 211 |
—
|
—
| 94.14K |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
| +0.38% | 357 |
—
|
—
| 93.93K |
Dec 31
| |||
Form 4
| +222.22% | 44.44K |
$90.00 | $3,999,960.00 | 64.44K |
Dec 11
| |||
Form 4
| +0.38% | 357 |
—
|
—
| 93.57K |
Oct 1
| |||
Form 4
| +47.46% | 30K |
$60.78 | $1,823,407.90 | 93.21K |
Sep 10
| |||
Form 4
| +0.57% | 357 |
—
|
—
| 63.21K |
Jul 1
| |||
Form 4
| +0.57% | 357 |
—
|
—
| 62.86K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 4
|
∞
| 20K |
$24.87 | $497,316.22 | 20K |
Dec 9
| |||
Form 4
|
∞
| 62.5K |
$16.00 | $1,000,000.00 | 62.5K |
Sep 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AMYLIN PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.00K |
$31.00 | -$186,000.00 |
0
|
Aug 8
| |||
Form 4
| +100.00% | 3K |
—
|
—
| 6K |
May 15
| |||
Form 4
|
∞
| 3K |
—
|
—
| 3K |
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ABGENIX INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -146.22K |
$22.50 | -$3,289,882.50 |
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||